Dividend

Cipher Pharmaceuticals Inc. Dividend

Dividend for Cipher Pharmaceuticals Inc. (PHE) on 6ix covers company data, market context, news, risks, and AI research briefs.

websitePHEDividend/analysis/PHE/dividend

Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PHE.

Stock profile

Ticker

PHE

Asset type

Stock

Market cap

$290.6M

Sector

Health Technology

Industry

Pharmaceuticals: Other

Currency

EUR

Ticker listings

Cipher Pharmaceuticals Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • CPH primary listing
  • CPHRF
  • PHE primary listing
  • A0B85L

Research sections

Valuation

Review valuation context for Cipher Pharmaceuticals Inc..

Future growth

Review future growth context for Cipher Pharmaceuticals Inc..

Past performance

Review past performance context for Cipher Pharmaceuticals Inc..

Financial health

Review financial health context for Cipher Pharmaceuticals Inc..

Dividend

Review dividend context for Cipher Pharmaceuticals Inc..

Management

Review management context for Cipher Pharmaceuticals Inc..

Ownership

Review ownership context for Cipher Pharmaceuticals Inc..

Other information

Review other information context for Cipher Pharmaceuticals Inc..

Community

Review community context for Cipher Pharmaceuticals Inc..